H
Harvest
Tax-loss replacement research
MRNA
Moderna Inc.
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for MRNA

Among the 28 Biotechnology peers screened, VRTX (Vertex Pharmaceuticals) has tracked MRNA most closely over the past year, with a return correlation of 0.28. The strongest fund stand-in is IBB (iShares Biotechnology ETF) at 0.49 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
VRTXVertex PharmaceuticalsBiotechnology0.280.210.200.18
AMGNAmgen Inc.Biotechnology0.230.210.190.17
RGENRepligenBiotechnology0.230.220.270.23
SRPTSarepta TherapeuticsBiotechnology0.220.180.180.15
KRYSKrystal BiotechBiotechnology0.220.200.190.16
BIIBBiogen Inc.Biotechnology0.210.240.200.15
REGNRegeneron PharmaceuticalsBiotechnology0.200.210.240.23
INCYIncyteBiotechnology0.200.210.220.20
XNCRXencor IncBiotechnology0.190.230.250.21
ALNYAlnylam PharmaceuticalsBiotechnology0.190.130.180.18
BMRNBioMarin PharmaceuticalBiotechnology0.190.190.210.16
VIRVir Biotechnology, Inc.Biotechnology0.190.200.270.26
GILDGilead SciencesBiotechnology0.180.160.180.20
TGTXTG Therapeutics, Inc.Biotechnology0.170.170.170.16
EXELExelixisBiotechnology0.160.130.140.13
HALOHalozymeBiotechnology0.150.140.160.15
ADMAADMA Biologics, Inc.Biotechnology0.130.130.150.09
RCUSArcus Biosciences, Inc.Biotechnology0.130.180.190.17
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.130.160.180.17
NBIXNeurocrine BiosciencesBiotechnology0.130.110.120.12
ROIVRoivant SciencesBiotechnology0.130.170.14
ARWRArrowhead PharmaceuticalsBiotechnology0.120.190.230.19
FTREFortreaBiotechnology0.110.140.14
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.110.100.11
CYTKCytokineticsBiotechnology0.100.120.120.12
UTHRUnited TherapeuticsBiotechnology0.080.110.100.09
VCELVericelBiotechnology0.070.120.170.13
PTGXProtagonist Therapeutics, Inc.Biotechnology0.050.090.110.08
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.490.450.480.42
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.400.380.370.33
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.390.380.390.34
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.350.310.320.25
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.340.320.330.26
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.340.310.320.25
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.320.300.310.23
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.290.270.270.21
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.260.250.260.22
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.250.270.280.23
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.190.190.240.20
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.080.100.130.09
NEXT STEPS

Harvesting a loss in MRNA?

RELATED

Replacement research for MRNA's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.